Retracted: Role of hypoxia‐inducible factors in the dexrazoxane‐mediated protection of cardiomyocytes from doxorubicin‐induced toxicity
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE: Iron aggravates the cardiotoxicity of doxorubicin, a widely used anticancer anthracycline, and the iron chelator dexrazoxane is the only agent protecting against doxorubicin cardiotoxicity; however, the mechanisms underlying the role of iron in doxorubicin‐mediated cardiotoxicity and the protective role of dexrazoxane remain to be established. As iron is required for the degradation of hypoxia‐inducible factors (HIF), which control the expression of antiapoptotic and protective genes, we tested the hypothesis that dexrazoxane‐dependent HIF activation may mediate the cardioprotective effect of dexrazoxane. EXPERIMENTAL APPROACH: Cell death, protein levels (by immunoblotting) and HIF‐mediated transcription (using reporter constructs) were evaluated in the rat H9c2 cardiomyocyte cell line exposed to low doses of doxorubicin with or without dexrazoxane pretreatment. HIF levels were genetically manipulated by transfecting dominant‐negative mutants or short hairpin RNA. KEY RESULTS: Treatment with dexrazoxane induced HIF‐1α and HIF‐2α protein levels and transactivation capacity in H9c2 cells. It also prevented the induction of cell death and apoptosis by exposure of H9c2 cells to clinically relevant concentrations of doxorubicin. Suppression of HIF activity strongly reduced the protective effect of dexrazoxane. Conversely, HIF‐1α overexpression protected against doxorubicin‐mediated cell death and apoptosis also in cells not exposed to the chelator. Exposure to dexrazoxane increased the expression of the HIF‐regulated, antiapoptotic proteins survivin, Mcl1 and haem oxygenase. CONCLUSIONS AND IMPLICATIONS: Our results showing HIF‐dependent prevention of doxorubicin toxicity in dexrazoxane‐treated H9c2 cardiomyocytes suggest that HIF activation may be a mechanism contributing to the protective effect of dexrazoxane against anthracycline cardiotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lee, K., Qian, D. Z., Rey, S., Wei, H., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812801106 · Cited by 289 · cited 5×
“…in cells exposed to dexrazoxane plus doxorubicin because doxorubicin, which affects the expression of muscle-specific genes (Ito et al., 1990) and HIF1-dependent transcriptional activity (Lee et al., 2009), may blunt HIF-1 activation and thus impair the protective effect of iron chelation.”
BackgroundMethodInfluentialRetractedOxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068 · cited 4×
“It has been previously shown that this transcription factor, which plays a key role in regulating alterations in the expression of genes that promote cell survival and maintain homeostasis (Schofield and Ratcliffe, 2004; Higgins et al., 2008; Semenza, 2009), is central to cardioprotection in models of ischaemic precon…”
BackgroundInfluentialWang, G., & Semenza, G. (1993) · Blood · doi:10.1182/blood.v82.12.3610.3610 · Cited by 766
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31370 · Cited by 639 · cited 1×
“…et al., 1999), or growth under iron deficiency condi- tions (Jones et al., 2006; Knowles et al., 2006), is associated with a high level of HIF-1 activity in cultured cells, and HIF-1 has been induced in vivo by iron depletion (Dongiovanni et al., 2008) or starvation (Peyssonnaux et al., 2007).”
BackgroundScortegagna, M., Ding, K., Oktay, Y., Gaur, A., Thurmond, F., Yan, L.-J., Marck, B. T., Matsumoto, A. M., Shelton, J. M., Richardson, J. A., et al. (2003) · Nature Genetics · doi:10.1038/ng1266 · Cited by 496
Role of the hypoxia inducible factors HIF in iron metabolism
Peyssonnaux, C., Nizet, V., & Johnson, R. S. (2008) · Cell Cycle · doi:10.4161/cc.7.1.5145 · Cited by 217 · cited 4×
“Dexrazoxane induces HIF binding activity and transactivation capacity in H9c2 cells As it has been shown that the depletion of cellular iron stores leads to the induction of HIF-1 (Peyssonnaux et al., 2008; Mole, 2010), we investigated whether dexrazoxane activates HIF-1 in cardiomyocytes.”
BackgroundInfluentialHIF-1-mediated activation of transferrin receptor gene transcription by iron chelation
Bianchi, L., Tacchini, L., & Cairo, G. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.21.4223 · Cited by 189
Self-citationTacchini, L., Gammella, E., De Ponti, C., Recalcati, S., & Cairo, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800365200 · Cited by 132 · cited 10×
“These ROS can then be converted into the more potent hydroxyl radical OH•, which is capable of damaging DNA and proteins, and initiating lipid peroxidation.”
BackgroundInfluentialSelf-citationKnowles, H. J., Mole, D. R., Ratcliffe, P. J., & Harris, A. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2351 · Cited by 94 · cited 2×
“…such as desferrioxamine (DFO) (Wang and Semenza, 1993; Bianchi et al., 1999), or growth under iron deficiency condi- tions (Jones et al., 2006; Knowles et al., 2006), is associated with a high level of HIF-1 activity in cultured cells, and HIF-1 has been induced in vivo by iron depletion…”
Background
Cited by
Kalam, K., & Marwick, T. H. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.04.030 · Cited by 343
Packer, M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa064 · Cited by 86
Tanaka, T., Yamaguchi, J., Shoji, K., & Nangaku, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374587 · Cited by 50
“To date, the molecular mechanisms of DXR cardiac toxicity remain incompletely understood, but a recent study attributes a protective role of dexrazoxane, a prodrug that is enzymatically hydrolyzed inside cardiomyocytes to its active metal-chelatingmetabolite, to HIF (33).”
BackgroundIron Chelators with Topoisomerase-Inhibitory Activity and Their Anticancer Applications
Rao, V. A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4877 · Cited by 37
Metadata
- Authors
- Spagnuolo, R., Recalcati, S., Tacchini, L., & Cairo, G.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-04-18
- Volume
- 163
- Issue
- 2
- Pages
- 299-312
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1486883346
- Cited by
- 41
- References
- 11
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retracted: Role of hypoxia‐inducible factors in the dexrazoxane‐mediated protection of cardiomyocytes from doxorubicin‐induced toxicity. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01208.x
- The paper
- Spagnuolo, R., Recalcati, S., Tacchini, L., & Cairo, G. (2011). Retracted: Role of hypoxia‐inducible factors in the dexrazoxane‐mediated protection of cardiomyocytes from doxorubicin‐induced toxicity. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01208.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.